These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 33269902)

  • 1. Exposure to Per- and Polyfluoroalkyl Substances and Adiposity at Age 12 Years: Evaluating Periods of Susceptibility.
    Liu Y; Li N; Papandonatos GD; Calafat AM; Eaton CB; Kelsey KT; Chen A; Lanphear BP; Cecil KM; Kalkwarf HJ; Yolton K; Braun JM
    Environ Sci Technol; 2020 Dec; 54(24):16039-16049. PubMed ID: 33269902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gestational and childhood exposure to per- and polyfluoroalkyl substances and cardiometabolic risk at age 12 years.
    Li N; Liu Y; Papandonatos GD; Calafat AM; Eaton CB; Kelsey KT; Cecil KM; Kalkwarf HJ; Yolton K; Lanphear BP; Chen A; Braun JM
    Environ Int; 2021 Feb; 147():106344. PubMed ID: 33418195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of prenatal and postnatal exposure to perfluoroalkyl substances with pubertal development and reproductive hormones in females and males: The HOME study.
    Liu Y; Calafat AM; Chen A; Lanphear BP; Jones NY; Cecil KM; Rose SR; Yolton K; Buckley JP; Braun JM
    Sci Total Environ; 2023 Sep; 890():164353. PubMed ID: 37225096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations of Prenatal Per- and Polyfluoroalkyl Substance (PFAS) Exposures with Offspring Adiposity and Body Composition at 16-20 Years of Age: Project Viva.
    Zhang M; Rifas-Shiman SL; Aris IM; Fleisch AF; Lin PD; Nichols AR; Oken E; Hivert MF
    Environ Health Perspect; 2023 Dec; 131(12):127002. PubMed ID: 38054701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perfluoroalkyl Substances during Pregnancy and Offspring Weight and Adiposity at Birth: Examining Mediation by Maternal Fasting Glucose in the Healthy Start Study.
    Starling AP; Adgate JL; Hamman RF; Kechris K; Calafat AM; Ye X; Dabelea D
    Environ Health Perspect; 2017 Jun; 125(6):067016. PubMed ID: 28669937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prenatal exposure to per- and polyfluoroalkyl substances and early childhood adiposity and cardiometabolic health in the Healthy Start study.
    Starling AP; Friedman C; Boyle KE; Adgate JL; Glueck DH; Allshouse WB; Calafat AM; Bloemsma LD; Dabelea D
    Int J Obes (Lond); 2024 Feb; 48(2):276-283. PubMed ID: 38042932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of Gestational Perfluoroalkyl Substances Exposure with Early Childhood BMI
    Liu Y; Wosu AC; Fleisch AF; Dunlop AL; Starling AP; Ferrara A; Dabelea D; Oken E; Buckley JP; Chatzi L; Karagas MR; Romano ME; Schantz S; O'Connor TG; Woodruff TJ; Zhu Y; Hamra GB; Braun JM;
    Environ Health Perspect; 2023 Jun; 131(6):67001. PubMed ID: 37283528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal exposure to Per- and polyfluoroalkyl substances and adiposity measures of children at 4 and 6 years: A prospective birth cohort in China.
    Sun S; Xie Z; Song X; Wen S; Yuan W; Miao M; Ji H; Liang H
    Ecotoxicol Environ Saf; 2024 Jan; 269():115751. PubMed ID: 38042132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal exposure to perfluoroalkyl substances and birth outcomes in a Spanish birth cohort.
    Manzano-Salgado CB; Casas M; Lopez-Espinosa MJ; Ballester F; Iñiguez C; Martinez D; Costa O; Santa-Marina L; Pereda-Pereda E; Schettgen T; Sunyer J; Vrijheid M
    Environ Int; 2017 Nov; 108():278-284. PubMed ID: 28917208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perfluorooctanoate and perfluorooctane sulfonate in umbilical cord blood and child cognitive development: Hamamatsu Birth Cohort for Mothers and Children (HBC Study).
    Oh J; Shin HM; Nishimura T; Rahman MS; Takahashi N; Tsuchiya KJ
    Environ Int; 2022 May; 163():107215. PubMed ID: 35378444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prenatal exposure to per- and polyfluoroalkyl substances (PFAS) and neurobehavior in US children through 8 years of age: The HOME study.
    Vuong AM; Webster GM; Yolton K; Calafat AM; Muckle G; Lanphear BP; Chen A
    Environ Res; 2021 Apr; 195():110825. PubMed ID: 33545124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma per- and polyfluoroalkyl substance mixtures during pregnancy and duration of breastfeeding in the New Hampshire birth cohort study.
    Romano ME; Gallagher LG; Price G; Crawford KA; Criswell R; Baker E; Botelho JC; Calafat AM; Karagas MR
    Int J Hyg Environ Health; 2024 May; 258():114359. PubMed ID: 38521049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal Exposure to Perfluoroalkyl Substances and Adiposity in Early and Mid-Childhood.
    Mora AM; Oken E; Rifas-Shiman SL; Webster TF; Gillman MW; Calafat AM; Ye X; Sagiv SK
    Environ Health Perspect; 2017 Mar; 125(3):467-473. PubMed ID: 27352404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exposure to per- and polyfluoroalkyl substances in early pregnancy and risk of cerebral palsy in children.
    Vilhelmsson A; Rylander L; Jöud A; Lindh CH; Mattsson K; Liew Z; Guo P; Ritz B; Källén K; Thacher JD
    Sci Total Environ; 2023 Nov; 899():165622. PubMed ID: 37474063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations of cord plasma per- and polyfluoroakyl substances (PFAS) with neonatal and child body composition and adiposity: The GUSTO study.
    Chen LW; Ng S; Tint MT; Michael N; Sadananthan SA; Ong YY; Yuan WL; Chen ZY; Chen CY; Godfrey KM; Tan KH; Gluckman PD; Chong YS; Eriksson JG; Yap F; Lee YS; Fortier MV; Velan SS; Chan SY
    Environ Int; 2024 Jan; 183():108340. PubMed ID: 38043321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prenatal exposure to per- and polyfluoroalkyl substances and infant growth and adiposity: the Healthy Start Study.
    Starling AP; Adgate JL; Hamman RF; Kechris K; Calafat AM; Dabelea D
    Environ Int; 2019 Oct; 131():104983. PubMed ID: 31284113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Determination of seven perfluoroalkyl and polyfluoroalkyl substances in serum of pregnant women and evaluation of neonatal neurobehavior based on high performance liquid chromatography-tandem mass spectrometry].
    Wang ZH; Liang FZ; Chen XR; Wu P; Wu W
    Se Pu; 2024 Feb; 42(2):194-202. PubMed ID: 38374600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations of Maternal Serum Perfluoroalkyl Substances Concentrations with Early Adolescent Bone Mineral Content and Density: The Health Outcomes and Measures of the Environment (HOME) Study.
    Buckley JP; Kuiper JR; Lanphear BP; Calafat AM; Cecil KM; Chen A; Xu Y; Yolton K; Kalkwarf HJ; Braun JM
    Environ Health Perspect; 2021 Sep; 129(9):97011. PubMed ID: 34585601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal concentrations of polyfluoroalkyl compounds during pregnancy and fetal and postnatal growth in British girls.
    Maisonet M; Terrell ML; McGeehin MA; Christensen KY; Holmes A; Calafat AM; Marcus M
    Environ Health Perspect; 2012 Oct; 120(10):1432-7. PubMed ID: 22935244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between prenatal exposure to per- and polyfluoroalkyl substances and infant anthropometry: A prospective cohort study.
    Li J; Su X; Zhou Y; Ji H; Xie Z; Sun S; Wang Z; Yuan W; Miao M; Liang H
    Int J Hyg Environ Health; 2024 Apr; 257():114339. PubMed ID: 38401404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.